FSBI "Scientific Research Institute of Physyology and Basic Medicine" under the SB of RAMS
Novosibirsk, Russian Federation
Research institute in Novosibirsk
Prospekt Akademika Lavrent'yeva, 8, Novosibirsk, Novosibirsk Oblast, 630090
About FSBI "Scientific Research Institute of Physyology and Basic Medicine" under the SB of RAMS
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Celgene
8
Shire
3
Takeda
3
Boehringer Ingelheim
2
Hoffmann-La Roche
2
Kowa Research Institute, Inc.
2
Pfizer
2
Clinical Trials at FSBI "Scientific Research Institute of Physyology and Basic Medicine" under the SB of RAMS
During the past decade, FSBI "Scientific Research Institute of Physyology and Basic Medicine" under the SB of RAMS conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 15 clinical trials were completed, i.e. on
average, 88.2% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 10 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
2012-07-20
2016-05-27
Completed
593
Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
2012-10-01
2020-08-06
Completed
944
Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA)
2013-07-10
2018-01-18
Completed
6,991
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
2014-09-15
2025-08-16
Active, not recruiting
1,822
A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitors
2014-11-14
2020-05-25
Completed
358
Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis
2015-06-17
2020-06-17
Completed
1,012
An Efficacy and Safety Study of Vedolizumab Intravenous (IV) Compared to Adalimumab Subcutaneous (SC) in Participants With Ulcerative Colitis
2015-06-29
2019-01-18
Completed
771
An Extension Study of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis
2015-12-02
2025-02-27
Active, not recruiting
878
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "FSBI "Scientific Research Institute of Physyology and Basic Medicine" under the SB of RAMS" #1 sponsor was "Celgene" with 8 trials, followed by "Shire" with 3 trials
sponsored, "Takeda" with 3 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored and "Hoffmann-La Roche"
with 2 trials sponsored. Other sponsors include -1 different institutions and
companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "FSBI "Scientific Research Institute of Physyology and Basic Medicine" under the SB of RAMS"
#1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at FSBI "Scientific Research Institute of Physyology and Basic Medicine" under the SB of RAMS
According to Clinical.Site data, the most researched conditions in "FSBI "Scientific Research Institute of Physyology and Basic Medicine" under the SB of RAMS" are
"Ulcerative Colitis" (9 trials), "Crohn Disease" (6 trials), "Crohn's Disease" (3 trials), "Colitis, Ulcerative" (2 trials) and "Severe Hypertriglyceridemia" (2 trials). Many other conditions were trialed in "FSBI "Scientific Research Institute of Physyology and Basic Medicine" under the SB of RAMS" in a lesser frequency.
Clinical Trials Intervention Types at FSBI "Scientific Research Institute of Physyology and Basic Medicine" under the SB of RAMS
Most popular intervention types in "FSBI "Scientific Research Institute of Physyology and Basic Medicine" under the SB of RAMS" are "Drug" (22 trials) and "Other" (6 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (11 trials), "GED-0301" (3 trials), "Ozanimod" (3 trials), "Adalimumab" (2 trials) and "CP-690,550" (2 trials). Other intervention names were less common.
Clinical Trials Genders at FSBI "Scientific Research Institute of Physyology and Basic Medicine" under the SB of RAMS
The vast majority of trials in "FSBI "Scientific Research Institute of Physyology and Basic Medicine" under the SB of RAMS" are
22 trials for "All" genders.
Clinical Trials Status at FSBI "Scientific Research Institute of Physyology and Basic Medicine" under the SB of RAMS
Currently, there are NaN active trials in "FSBI "Scientific Research Institute of Physyology and Basic Medicine" under the SB of RAMS".
undefined are not yet recruiting,
3 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 12 completed trials in FSBI "Scientific Research Institute of Physyology and Basic Medicine" under the SB of RAMS,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in FSBI "Scientific Research Institute of Physyology and Basic Medicine" under the SB of RAMS, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 21 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".